Home >> Industry News >> Companies
sideview vmo3D sideview vmo3D 30 day free trial
  • Also available via:

Luxottica Working on New Version of Google Glass PDF
Submit Your News
Tuesday, 28 April 2015

Google Glass 2According to recent reports in the Wall Street Journal and Forbes, Luxottica is working on a new version of Google Glass.

Luxottica's CEO Massimo Vian told shareholders at the recent company's general meeting that its partnership with Google to build the next iteration of Glass is moving forward and will be available soon. Google's Executive Chairman Eric Schmidt told The Wall Street Journal that Google Glass has been put under the leadership of Tony Fadell, head of Google's Nest connected home division, in order to make it ready for consumers.

Luxottica also confirmed that it is going ahead with a partnership with Intel, and that a first product will be out between February and March next year.

Essilor Reports Strong First Quarter 2015 PDF
Submit Your News
Friday, 24 April 2015

Essilor International has announced that consolidated revenue for the first quarter of 2015 totaled €1,659 million, representing an increase of 12.7% excluding the currency effect. Hubert Sagnières, Chairman and CEO of Essilor, said: "This first-quarter 2015 performance confirms our strong growth potential, which is benefiting from the broadening of our playing field and the extension of our geographical reach to meet the multiple eyesight correction and visual protection needs around the world. Excluding Japan, mature markets picked up pace while fast-growing markets remained vibrant despite the lackluster economic environment in certain countries. Business momentum should continue to accelerate throughout the year on the back of the ramp-up of the media campaigns and recent contract wins for our different businesses, as well as the contribution of new local partnerships. That is why we are confident that our full-year 2015 targets will be met."

The company also reported that Australia enjoyed strong sales impetus.

Avalanche Biotechnologies Announces Gene Therapy Medicines to Treat Color Blindness PDF
Submit Your News
Monday, 13 April 2015

Color Vision AwarenessUS company Avalanche Biotechnologies recently announced that it has entered into an exclusive license agreement with the University of Washington (UW) in Seattle to develop products based on Avalanche's proprietary Ocular BioFactory™ Platform for the treatment of color vision deficiency (CVD), commonly known as red-green color blindness.

Avalanche will build on gene therapy research conducted by the research team at the UW. They used gene therapy to confer color vision in two adult male squirrel monkeys that had been colorblind since birth. This groundbreaking work demonstrating proof-of-concept for treating CVD was published in the journal Nature.

In addition, Avalanche launched, a disease awareness website designed to help people suffering from color blindness better understand their condition. The website provides the opportunity for people to sign up to be among the first to receive information about potential research study opportunities or therapies for color blindness that become available.

Lindberg Accuses Rodenstock of Copyright Infringement PDF
Submit Your News
Thursday, 02 April 2015

Lindberg - RodenstockDanish eyewear company Lindberg has accused Rodenstock of copyright infringement of its LINDBERG 7000 and LINDBERG 9800 models. The company has detailed the similarities on their company website with Rodenstock's Mercedes-Benz eyewear collection.

Lindberg states on its website: "We are determined to protect the uniqueness of our designs, our ideas and our technical solutions. They are the absolute essence of our brand identity. LINDBERG constantly encounters products that bear such resemblance to the design characteristics of our products and/or technical details that we are of the opinion that consumers might confuse the respective products. These images are an example of this."

Hoya Invests in Wet AMD Therapy Technology PDF
Submit Your News
Wednesday, 01 April 2015

Hoya Wet AMD TherapyHOYA Group recently announced that it has closed an investment financing in Salutaris Medical Devices, Inc. (SalutarisMD®). SalutarisMD will use the funding to further its growth strategy in developing its patented medical device designed for minimally invasive therapy of wet age-related macular degeneration (wet AMD).

Wet AMD is a leading cause of vision loss and blindness that primarily affects older adults.

"Our investment in SalutarisMD continues HOYA's commitment to establishing strong relationships with companies developing next-generation products for medical care, particularly in the area of minimally invasive therapeutic technologies," said Augustine Yee, Executive Officer, Chief Legal Officer and Head of Corporate Development and Affairs at HOYA Corporation. "The SalutarisMD technology offers the potential to meaningfully impact the management of wet AMD. We are pleased to build this strategic relationship with an innovative company in our growing Life Care space."

"The currently available treatment regimens for wet AMD are costly, burdensome and there is a large unmet need for more effective therapies. We are excited about our partnership with HOYA that will further enable our commercialization efforts," said Dr. Laurence Marsteller, CEO of SalutarisMD.

The SalutarisMD device is designed to provide precise lesion-specific targeting. The procedure is performed using a hand-held instrument under the direct care and expertise of the treating retina specialist to deliver localized tissue irradiation, customized for each patient. The SalutarisMD device is designed as a practical, clinic-based procedure.

Salvatore Ferragamo Extends License Agreement with Marchon Eyewear PDF
Submit Your News
Thursday, 26 March 2015

Salvatore Ferragamo S.p.A., the parent company of the Salvatore Ferragamo Group and one of the leading players in the global luxury industry, has announced that it has agreed to a five-year extension to its worldwide licensing agreement for the design, distribution, marketing and sale of "Salvatore Ferragamo" branded sunglasses and optical frames for men and women with Marchon Eyewear, Inc., one of the leading companies in the eyewear sector.

The licensing agreement, which first went into effect on January 1, 2012, will now run until December 2021.

Produced exclusively in Italy, the Salvatore Ferragamo eyewear collections are the perfect interpretation of the brand's history, heritage and style. The collections are distributed all over the world in Salvatore Ferragamo mono-brand boutiques and in leading stores and specialist opticians.

<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Page 1 of 114